Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
ALNYLAM PHARMACEUTICALS, INC. has filed 1,657 SEC EDGAR filings since 09 Jul 2002

SEC filing history

Showing 126-150 of 207 matching filings.

Per page
25
Current page
6
8-K File 001-36407

FORM 8-K

Filing date
10 Jul 2015
Reporting date
06 Jul 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

8-K

Filing date
10 Jun 2015
Reporting date
08 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date
07 May 2015
Reporting date
07 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

FORM 8-K

Filing date
05 May 2015
Reporting date
01 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

FORM 8-K

Filing date
06 Apr 2015
Reporting date
03 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date
12 Feb 2015
Reporting date
12 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

FORM 8-K

Filing date
03 Feb 2015
Reporting date
03 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

FORM 8-K

Filing date
26 Jan 2015
Reporting date
20 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

8-K

Filing date
14 Jan 2015
Reporting date
08 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

8-K

Filing date
08 Jan 2015
Reporting date
08 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

8-K

Filing date
19 Dec 2014
Reporting date
17 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

8-K

Filing date
18 Dec 2014
Reporting date
17 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date
05 Nov 2014
Reporting date
05 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

FORM 8-K

Filing date
26 Sep 2014
Reporting date
25 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

ALNYLAM PHARMACEUTICALS 8-K

Filing date
07 Aug 2014
Reporting date
07 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

FORM 8-K

Filing date
02 Jul 2014
Reporting date
01 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

ALNYLAM PHARMACEUTICALS 8-K

Filing date
07 Aug 2014
Reporting date
07 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

FORM 8-K

Filing date
02 Jul 2014
Reporting date
01 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36407

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date
08 May 2014
Reporting date
08 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50743

FORM 8-K

Filing date
02 Apr 2014
Reporting date
27 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50743

FORM 8-K

Filing date
24 Mar 2014
Reporting date
18 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50743

FORM 8-K

Filing date
06 Mar 2014
Reporting date
05 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50743

FORM 8-K

Filing date
27 Feb 2014
Reporting date
27 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50743

FORM 8-K

Filing date
26 Feb 2014
Reporting date
21 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50743

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date
13 Feb 2014
Reporting date
13 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .